Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC
· Real-Time Price · USD
13.84
0.12 (0.87%)
At close: Oct 03, 2025, 3:59 PM
13.84
0.00%
After-hours: Oct 03, 2025, 04:10 PM EDT
Benitec Biopharma Income Statement
Financials in USD. Fiscal
year is
July - June.
| Fiscal Year | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
Revenue | 556K | n/a | n/a | n/a | n/a | 6K | n/a | n/a | 7K | 54K | 14K | 472K | n/a | 48K | 25K | n/a | 2K | 1K | 1K | 55K |
Cost of Revenue | 278K | 106K | 81K | 91K | 91K | 90K | 1K | -106K | 84K | n/a | 41K | 102K | 9K | n/a | n/a | 102K | 1K | 7K | 24.64K | 134K |
Gross Profit | 278K | -106K | -81K | -91K | -91K | 3K | -1K | 106K | -77K | 54K | -27K | 370K | -9K | 48K | 25K | -102K | 1K | -6K | -23.64K | -79K |
Operating Income | -17.18M | -10.19M | -8.61M | -5.79M | -5.55M | -4.14M | -6.93M | -5.87M | -4.55M | -4.34M | -5.61M | -4.58M | -4.74M | -3.46M | -4.83M | -4.82M | -3.85M | -3.79M | -3.26M | -2.69M |
Interest Income | -2.25M | 823K | 823K | 604K | 920K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -16.15M | -9.35M | -7.36M | -5.06M | -4.72M | -4.28M | -6.8M | -5.95M | -4.66M | -4.4M | -5.41M | -5.09M | -5.07M | -3.27M | -4.82M | -5.04M | -4M | -3.91M | -3.25M | -2.72M |
Net Income | -16.15M | -9.35M | -7.36M | -5.06M | -4.72M | -4.28M | -6.8M | -5.95M | -4.66M | -4.4M | -5.21M | -5.61M | -5.07M | -3.09M | -4.82M | -5.04M | -4M | -3.91M | -3.25M | -2.72M |
Selling & General & Admin | 13.48M | 4.21M | 3.54M | 2.21M | 2.04M | 1.49M | 1.82M | 1.55M | 1.37M | 1.23M | 1.86M | 1.92M | 1.55M | 1.34M | 1.71M | 2.04M | 1.54M | 1.03M | 2.11M | 1.84M |
Research & Development | 3.69M | 5.98M | 5.07M | 3.58M | 3.51M | 2.57M | 5.1M | 4.43M | 3.19M | 3.17M | 3.76M | 2.66M | 3.18M | 2.17M | 3.15M | 2.78M | 2.32M | 2.76M | 1.17M | 774K |
Other Expenses | n/a | n/a | n/a | n/a | n/a | 90K | n/a | n/a | -80K | n/a | 50K | n/a | n/a | -29K | n/a | n/a | n/a | 7K | 10K | n/a |
Operating Expenses | 17.18M | 10.19M | 8.61M | 5.79M | 5.55M | 4.14M | 6.93M | 5.98M | 4.56M | 4.39M | 5.62M | 4.58M | 4.73M | 3.51M | 4.86M | 4.82M | 3.86M | 3.79M | 3.28M | 2.61M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 4K | 6K | 6K | 8K | 7K | 9K | 9K | 10K | 10K | 11K | 1K | n/a | 2K | 2K | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | 77K | -90K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 17.45M | 10.19M | 8.61M | 5.79M | 5.55M | 4.14M | 6.93M | 5.87M | 4.56M | 4.39M | 5.62M | 4.58M | 4.74M | 3.51M | 4.86M | 4.82M | 3.86M | 3.79M | 3.26M | 2.75M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -10K | n/a | n/a | n/a | -199K | 513K | -40K | -185K | 11K | n/a | n/a | n/a | 3K | n/a |
Shares Outstanding (Basic) | 36.21M | 38.6M | 22.08M | 10.64M | 10.09M | 10.44M | 10.3M | 8.63M | 6.58M | 1.65M | 6.48M | 2.55M | 1.92M | 1.92M | 1.92M | 1.92M | 1.66M | 1.12M | 1.01M | 260.79K |
Shares Outstanding (Diluted) | 36.21M | 38.6M | 22.08M | 10.64M | 10.09M | 10.47M | 10.31M | 8.63M | 6.58M | 1.65M | 6.49M | 2.55M | 1.92M | 1.92M | 1.92M | 1.92M | 1.66M | 1.12M | 1.01M | 260.79K |
EPS (Basic) | -0.21 | -0.24 | -0.33 | -0.48 | -0.53 | -0.23 | -1.32 | -1.38 | -1.42 | -2.67 | -1.61 | -4.39 | -5.27 | -3.21 | -5.01 | -5.25 | -4.82 | -7 | -6.43 | -20.84 |
EPS (Diluted) | -0.21 | -0.24 | -0.33 | -0.48 | -0.53 | -0.23 | -1.32 | -1.38 | -1.42 | -2.67 | -1.6 | -4.39 | -5.27 | -3.21 | -5.01 | -5.25 | -4.82 | -7 | -6.43 | -20.84 |
EBITDA | -19.02M | -9.25M | -8.53M | -4.97M | -4.64M | -4.18M | -6.71M | -5.87M | -4.57M | -4.3M | -5.36M | -4.98M | -5M | -3.15M | -4.71M | -4.94M | -3.8M | -3.79M | -3.19M | -2.6M |
EBIT | -18.74M | -9.35M | -8.61M | -5.06M | -4.74M | -4.28M | -6.79M | -5.95M | -4.65M | -4.39M | -5.4M | -5.08M | -5.06M | -3.27M | -4.82M | -5.04M | -3.85M | -3.91M | -3.25M | -2.69M |
Depreciation & Amortization | -278K | 106K | 81K | 91K | 91K | 90K | 80K | 82K | 84K | 93K | 41K | 102K | 63K | 114K | 113K | 102K | 102K | 115K | 115K | 92K |